Logo image of LIZI

LIZHI INC (LIZI) Stock Fundamental Analysis

NASDAQ:LIZI - Nasdaq - US53933L2034 - ADR - Currency: USD

2.8  +0.06 (+2.19%)

After market: 2.89 +0.09 (+3.21%)

Fundamental Rating

5

LIZI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. Both the profitability and the financial health of LIZI get a neutral evaluation. Nothing too spectacular is happening here. LIZI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes LIZI very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year LIZI was profitable.
LIZI had negative earnings in 4 of the past 5 years.
In multiple years LIZI reported negative operating cash flow during the last 5 years.
LIZI Yearly Net Income VS EBIT VS OCF VS FCFLIZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -200M -400M -600M -800M -1B

1.2 Ratios

LIZI's Return On Assets of 14.87% is amongst the best of the industry. LIZI outperforms 97.26% of its industry peers.
LIZI has a Return On Equity of 23.66%. This is amongst the best in the industry. LIZI outperforms 93.15% of its industry peers.
With an excellent Return On Invested Capital value of 14.23%, LIZI belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROIC 14.23%
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIZI Yearly ROA, ROE, ROICLIZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 -500 1K 1.5K 2K

1.3 Margins

Looking at the Profit Margin, with a value of 4.79%, LIZI belongs to the top of the industry, outperforming 80.82% of the companies in the same industry.
LIZI has a better Operating Margin (3.72%) than 65.75% of its industry peers.
LIZI has a Gross Margin (31.28%) which is in line with its industry peers.
In the last couple of years the Gross Margin of LIZI has grown nicely.
Industry RankSector Rank
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
LIZI Yearly Profit, Operating, Gross MarginsLIZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIZI is creating value.
LIZI has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LIZI has been reduced compared to a year ago.
LIZI Yearly Shares OutstandingLIZI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
LIZI Yearly Total Debt VS Total AssetsLIZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that LIZI is in the distress zone and has some risk of bankruptcy.
LIZI has a Altman-Z score (0.35) which is in line with its industry peers.
A Debt/Equity ratio of 0.01 indicates that LIZI is not too dependend on debt financing.
LIZI's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. LIZI outperforms 78.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACC1.94
WACC7.35%
LIZI Yearly LT Debt VS Equity VS FCFLIZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

LIZI has a Current Ratio of 2.58. This indicates that LIZI is financially healthy and has no problem in meeting its short term obligations.
LIZI has a Current ratio of 2.58. This is amongst the best in the industry. LIZI outperforms 80.82% of its industry peers.
A Quick Ratio of 2.58 indicates that LIZI has no problem at all paying its short term obligations.
LIZI has a Quick ratio of 2.58. This is amongst the best in the industry. LIZI outperforms 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
LIZI Yearly Current Assets VS Current LiabilitesLIZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

LIZI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1683.33%, which is quite impressive.
The Revenue has grown by 13.31% in the past year. This is quite good.
Measured over the past years, LIZI shows a very strong growth in Revenue. The Revenue has been growing by 36.96% on average per year.
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%

3.2 Future

LIZI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -48.05% yearly.
Based on estimates for the next years, LIZI will show a very strong growth in Revenue. The Revenue will grow by 114.98% on average per year.
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIZI Yearly Revenue VS EstimatesLIZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
LIZI Yearly EPS VS EstimatesLIZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.92, the valuation of LIZI can be described as very cheap.
Based on the Price/Earnings ratio, LIZI is valued cheaper than 100.00% of the companies in the same industry.
LIZI is valuated cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
LIZI is valuated reasonably with a Price/Forward Earnings ratio of 10.34.
Based on the Price/Forward Earnings ratio, LIZI is valued cheaply inside the industry as 89.04% of the companies are valued more expensively.
LIZI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
LIZI Price Earnings VS Forward Price EarningsLIZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.38
LIZI Per share dataLIZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

LIZI's earnings are expected to decrease with -48.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LIZI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIZHI INC

NASDAQ:LIZI (1/24/2024, 8:00:03 PM)

After market: 2.89 +0.09 (+3.21%)

2.8

+0.06 (+2.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)03-14 2024-03-14/amc
Inst Owners1.35%
Inst Owner Change188.29%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.82M
Analysts85.71
Price Target1.43 (-48.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA -5.38
EPS(TTM)3.04
EY108.57%
EPS(NY)0.27
Fwd EY9.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS62.58
BVpS12.66
TBVpS12.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROCE 18.29%
ROIC 14.23%
ROICexc N/A
ROICexgc N/A
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
FCFM N/A
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
F-ScoreN/A
Asset Turnover3.11
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 0.35
F-ScoreN/A
WACC7.35%
ROIC/WACC1.94
Cap/Depr(3y)93.44%
Cap/Depr(5y)138.6%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A
EBIT growth 1Y1575%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-82.2%
EBIT Next 3Y15.08%
EBIT Next 5YN/A
FCF growth 1Y303.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y437.38%
OCF growth 3YN/A
OCF growth 5YN/A